Published on 23 Sep 2023 on Simply Wall St. via Yahoo Finance
Avadel Pharmaceuticals plc's (NASDAQ:AVDL) institutional investors lost 7.6% last week but have...
Key Insights
Significantly high institutional ownership implies Avadel Pharmaceuticals' stock price is sensitive to their trading actions50% of the business is held by the top 12 shareholders Insiders have sold recently
If you want to know who really controls Avadel Pharmaceuticals plc (NASDAQ:AVDL), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions with 48% ownership. Put another way, the group faces the maximum upside potential (or downside risk).